Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells

Molecular and Cellular Biology

Volumn 18, Issue 3, 1998, Pages 1525-1533

  Kim, Hongkyun ^a   Hawley, Teresa S ^b   Hawley, Robert G ^b   Baumann, Heinz ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; PROTEIN TYROSINE PHOSPHATASE;

ARTICLE; CELL PROLIFERATION; DNA BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE TARGETING; HEMATOPOIESIS; LIVER CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

EID: 0031888837     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.3.1525     Document Type: Article

References (53)

1. Adachi, M., M. Ishino, T. Torigoe, Y. Minami, T. Matozaki, T. Miyazaki, T. Taniguchi, Y. Hinoda, and K. Imai. 1997. Interleukin-2 induces tyrosine phosphorylation of SHP-2 through IL-2 receptor beta chain. Oncogene 14:1629-1633.
2. Baumann, H., R. E. Hill, D. M. Sauder, and G. P. Jahreis. 1986. Regulation of major acute-phase plasma proteins by hepatocyle-stimulating factors of human squamous carcinoma cells. J. Cell. Biol. 102:370-383.
3. Baumann, H., C. Richards, and J. Gauldie. 1987. Interaction among hepatocyte-stimulating factors, interleukin 1 and glucocorticoid for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells. J. Immunol. 139:1422-1428.
4. Baumann, H., K. R. Prowse, S. Marinkovic, K.-A. Won, and G. P. Jahreis. 1989. Stimulation of hepatic acute phase response by cytokines and glucocorticoids. Ann. N.Y. Acad. Sci. 557:280-295.
5. Baumann, H., A. J. Symes, M. R. Comeau, K. K. Morella, Y. Wang, D. Friend, S. F. Ziegler, J. S. Fink, and D. P. Gearing. 1994. Multiple regions within the cytoplasmic domains of the leukemia inhibitory factor receptor and gp130 cooperate in signal transduction in hepatic and neuronal cells. Mol. Cell. Biol. 14:138-146.
6. Behrmann, I., C. Janzen, C. Gerhartz, de L. H. Schmitz-Van, H. Hermanns, B. Heesel, L. Graeve, F. Horn, J. Tavernier, and P. C. Heinrich. 1997. A single STAT recruitment module in a chimeric cytokine receptor complex is sufficient for STAT activation. J. Biol. Chem. 272:5269-5274.
7. Bennett, A. M., S. F. Hausdorff, A. M. O'Reilly, R. M. Freeman, Jr., and B. G. Nell. 1996. Multiple requirements for SHPTP2 in epidermal growth factor-mediated cell cycle progression. Mol. Cell. Biol. 16:1189-1202.
8. Berger, L. C., and R. G. Hawley. 1997. Interferon-β interrupts interleukin-6 dependent signaling events in myeloma cells. Blood 89:261-271.
9. Bone, H., U. Dechert, F. Jirik, J. W. Schrader, and M. J. Welham. 1997. SHP1 and SHP2 protein-tyrosine phosphatases associate with betac after interleukin-3-induced receptor tyrosine phosphorylation. J. Biol. Chem. 272:14470-14476.
10. Campos, S. P., Y. Wang, and H. Baumann. 1996. Insulin modulates STAT3 protein activation and gene in hepatic cells. J. Biol. Chem. 271:24418-24424.
11. Carlberg, K., and L. R. Rohrschneider. 1997. Characterization of a novel tyrosine phosphorylated 100-kDa protein that binds to SHP-2 and phosphatidylinositol 3′-kinase in myeloid cells. J. Biol. Chem. 272:15943-15950
12. Case, R. D., E. Piccione, G. Wolf, A. M. Benett, R. J. Lechleider, B. G. Neel, and S. E. Shoelson. 1994. SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides. J. Biol. Chem. 269:10467-10474.
13. Endo, T. A., M. Masuhara, M. Yokouchi, R. Suzuki, H. Sakamoto, K. Mitsui, A. Matsumoto, S. Tanimura, M. Ohtsubo, H. Misawa, T. Miyazaki, N. Leonor, T. Taniguchi, T. Fujita, Y. Kanakura, S. Komiya, and A. Yoshimura. 1997. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387:921-924.
14. Fukada, T., M. Hibi, Y. Yamanaka, M. Takahashi-Tezuka, Y. Fujitani, T. Yamaguchi, K. Nakajima, and T. Hirano. 1996. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in antiapoptosis. Immunity 5:449-460
15. 2/BSF-2 shares identity with monocytoe derived hepatocyte stimulating factor (HSF) and regualtes the major acute phase protein response in liver cells. Proc. Natl. Acad. Sci. USA 84:7251-7255.
16. Giordano, V., G. De Falco, R. Chiari, I. Quinto, P. G. Pelicci, L. Bartholomew, P. Delmastro, M. Gadina, and G. Scala. 1997. Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase. J. Immunol. 158:4097-4103.
17. Hawley, R. G., F. H. Lieu, A. Z. Fong, S. J. Goldman, J. P. Leonard, and T. S. Hawley. 1996. Retroviral vectors for production of interleukin-12 in the bone marrow to induce a graft-versus-leukemia effect. Ann. N.Y. Acad. Sci. 795:341-345.
18. Immenschuh, S., Y. Nagae, H. Satoh, H. Baumann, and U. Muller-Eberhard. 1994. The rat and human hemopexin genes contain an identical interleukin-6 response element that is not a target of CAT enhancer-binding protein isoforms. J. Biol. Chem. 269:12654-12661.
19. Jackson, D. E., C. M. Ward, R. Wang, and P. J. Newman. 1997. The protein-tyrosine phosphatase SHP-2 binds platelet/endothelial cell adhesion molecule-1 (PECAM-1) and forms a distinct signaling complex during platelet aggregation. J. Biol. Chem. 272:6986-6993.
20. Kazlauskas, A., G.-S. Feng, T. Pawson, and M. Valius. 1993. The 64-kDa protein that associates with the platelet-derived growth factor receptor β subunit via Tyr-1009 is the SH-2 containing phosphotyrosine phosphatase Syp. Proc. Natl. Acad. Sci. USA 90:6939-6942.
21. Kharitonenkov, A., Z. Chen, I. Sures, H. Wang, J. Schilling, and A. Ullrich. 1997. A family of proteins that inhibit signalling through tyrosine kinase receptors. Nature 386:181-186.
22. Kim, H., and H. Baumann. 1997. The carboxyl-terminal region of STAT3 controls gene induction by the mouse haptoglobin promoter. J. Biol. Chem. 272:14571-14579.
23. Kim, H., and H. Baumann. Unpublished data.
24. Klingmuller, U., U. Lorenz, L. C. Cantley, B. G. Neel, and H. F. Lodish. 1995. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 80:729-738.
25. Kuhne, M. R., T. Pawson, G. E. Lienhard, and G.-S. Feng. 1993. The insulin receptor substrate 1 associates with the SH-2 containing phophotyrosine phosphatase Syp. J. Biol. Chem. 268:11479-11481.
26. shc, Raf-1, and MEK-1 in the IL-6 induced mitogen-activated protein kinase cascade of growth responsive B cell line. J. Immunol. 152:4436-4447.
27. Lai, C.-F., J. Ripperger, K. K. Morella, Y. Wang, D. P. Gearing, G. H. Fey, and H. Baumann. 1995. Separate signaling mechanisms are involved in the control of STAT protein activation and gene regulation via the interleukin 6 response element by the box 3 motif of gp130. J. Biol. Chem. 270:14847-14850.
28. Lai, C.-F., J. Ripperger, K. K. Morella, Y. Wang, D. P. Gearing, N. D. Horseman, S. P. Campos, G. H. Fey, and H. Baumann. 1995. STAT3 and STAT5B are targets of two different signal pathways activated by hematopoietin receptors and control transcription via separate cytokine response elements. J. Biol. Chem. 270:23254-23257.
29. Li, W., R. Nishimura, A. Kashishian, A. G. Batzer, W. J. Kim, J. A. Cooper, and J. Schlessinger. 1994. A new function for a phosphotyrosine phosphatase: linking GRB2-Sos to a receptor tyrosine kinase. Mol. Cell. Biol. 14:509-517.
30. Liu, L., J. E. Damen, M. D. Ware, and G. Krystal. 1997. Interleukin-3 induces the association of the inositol 5-phosphatase SHIP with SHP2. J. Biol. Chem. 272:10998-11001.
31. Lutticken, C., U. M. Wegenka, J. Yuan, J. Buschmann, C. Schindle, A. Ziemiecki, A. G. Harpur, A. F. Wilks, K. Yasukawa, T. Taga, and T. Kishimoto. 1994. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science 263:89-92.
32. Matsuda, T., T. Fukada, M. Takahashi-Tezuka, Y. Okuyama, Y. Fujitani, Y. Hanazono, H. Hirai, and T. Hirano. 1995. Activation of Fes tyrosine kinase by gp130, an interleukin-6 family cytokine signal transducer, and their association. J. Biol. Chem. 270:11037-11034.
33. Matsuda, T., M. Takahashi-Tezuka, T. Fukada, Y. Okuyama, Y. Fujitani, S. Tsukada, H. Mano, H. Hirai, O. N. Witte, and T. Hirano. 1995. Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines. Blood 85:627-633.
34. Miller, A. D., and C. Buttimore. 1986. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6:2895-2902.
35. Morella, K. K., C.-F. Lai, S. Kumaki, N. Kumaki, Y. Wang, E. M. Bluman, B. A. Witthuhn, J. N. Ihle, J. Giri, D. P. Gearing, D. Cosman, S. F. Ziegler, D. J. Tweardy, S. P. Campos, and H. Baumann. 1995. The action of interleukin-2 receptor subunits defines a new type of signaling mechanism for hematopoictic receptors in hepatic cells and fibroblasts. J. Biol. Chem. 270:8298-8310.
36. Mosley, B., M. P. Beckmann, C. J. March, R. L. Idzerda, S. D. Gimpel, T. Vanden Bos, D. Friend, D. Anderson, J. Jackson, J. M. Wignall, C. Smith, B. Gallis, J. E. Sims, D. Urdal, M. B. Widmer, and D. Cosman. 1989. The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell 59:335-348.
37. Murakami, M., M. Narazaki, M. Hibi, H. Yawata, K. Yasukawa, M. Hamaguchi, T. Taga, and T. Kishimoto. 1991. Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. Proc. Natl. Acad. Sci. USA 88:11349-11353.
38. Naka, T., M. Narazaki, M. Hirata, T. Matsumoto, S. Minamoto, A. Aono, N. Nishimoto, T. Kajita, T. Taga, K. Yoshizaki, S. Akira, and T. Kishimoto. 1997. Structure and function of a new STAT-induced STAT inhibitor. Nature 387:924-929.
39. O'Mahoney, J. V., and T. E. Adams. 1994. Optimization of experimental variables influencing reporter gene expression in hepatoma cells following calcium phosphate transfection. DNA Cell Biol. 13:1227-1232.
40. Prowse, K. R., and H. Baumann. 1988. Hepatocyte-stimulating factor, beta-2 interferon, and interleukin-1 enhance expression of the rat alpha 1-acid glycoprotein gene via a distal upstream regulatory element. Mol. Cell. Biol. 8:42-51.
41. Sadowski, H. B., K. Shuai, J. E. Darnell, Jr., and M. Z. Gilman. 1993. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science 261:1739-1744.
42. Schiemann W. P., J. L. Bartoe, and N. M. Nathanson. 1997. Box 3-independent signaling mechanisms are involved in leukemia inhibitory factor receptor alpha-and gp130-mediated stimulation of mitogen-activated protein kinase. J. Biol. Chem. 272:16631-16636.
43. Stahl, N., T. J. Farruggella, T. G. Boulton, Z. Zhong, J. E. Darnell, Jr., and G. D. Yancopoulos. 1995. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267:1349-1353.
44. Stahl, N., T. G. Boulton, T. Farruggella, N. Y. Ip, S. Davis, B. A. Witthuhn, F. W. Quelle, O. Silvennoinen, G. Barbieri, S. Pellegrini, et al. 1994. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science 263:92-95.
45. Starr, R., T. A. Willson, E. M. Viney, L. J. Murray, J. R. Rayner, B. J. Jenkins, T. J. Gonda, W. S. Alexander, D. Metcalf, N. A. Nicola, and D. J. Hilton. 1997. A family of cytokine-inducible inhibitors of signalling. Nature 387:917-921.
46. Sturgill, T. W., L. B. Ray, E. Erikson, and J. L. Maller. 1988. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature 334:715-718.
47. Symes, A., N. Stahl, S. A. Reeves, T. Farruggella, T. Servidei, T. Gearan, G. Yancopoulos, and J. S. Fink. 1997. The protein tyrosine phosphatase SHP-2 negatively regulates ciliary neurotrophic factor induction of gene expression. Curr. Biol. 7:697-700.
48. Takahashi-Tezuka, M., M. Hibi, Y. Fujitani, T. Fukada, T. Yamaguchi, and T. Hirano. 1997. Tec tyrosine kinase links the cytokine receptors to PI-3 kinase probably through JAK. Oncogene 14:2273-2282.
49. Tauchi, T., J. E. Damen, K. Toyama, G. S. Feng, H. E. Broxmeyer, and G. Krystal. 1996. Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis. Blood 87:4495-4501.
50. Wang, X. Y., D. K. Fuhrer, M. S. Marshall, and Y. C. Yang. 1995. Interleukin-11 induces complex formation of Grb2, Fyn, and Jak2 in 3T3L1 cells. J. Biol. Chem. 270:27999-28002.
51. Wang, Y., K. K. Kuropatwinski, D. W. White, T. S. Hawley, R. G. Hawley, L. A. Tartaglia, and H. Baumann. 1997. Leptin receptor action in hepatic cells. J. Biol. Chem. 272:16216-16223.
52. Xia, S., D. W. Rose, T. Sasuoka, H. Maegawa, T. R. Burke, P. P. Roller, S. E. Shoelson, and J. M. Olefsky. 1994. SYP(SH-PTP2) is a positive mediator of growth factor-stimulated signal transduction. J. Biol. Chem. 269:21244-21248.
53. Yin, T., R. Shen, G.-S. Feng, and Y.-C. Yang. 1997. Molecular characterization of specific interactions between SHP-2 phosphatase and JAK tyrosine kinases. J. Biol. Chem. 272:1032-1037.